Tag: Nasdaq:IMNN

Health

IMUNON 2025, A TRANSFORMATIVE YEAR OF SIGNIFICANT CLINICAL ADVANCES, LOOKING AHEAD TO 2026

Enrollment in the Pivotal Phase 3 OVATION 3 Study Advances Company Toward Future…

By GlobeNews Wire

29/12/2025